Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks

Avian influenza virus (AIV) subtype H9N2 is the most widespread AIV in poultry worldwide, causing great economic losses in the global poultry industry. Chickens and ducks are the major hosts and play essential roles in the transmission and evolution of H9N2 AIV. Vaccines are considered an effective...

Full description

Bibliographic Details
Main Authors: Yuzhuo Liu, Dongmin Zhao, Jingfeng Zhang, Xinmei Huang, Kaikai Han, Qingtao Liu, Jing Yang, Lijiao Zhang, Yin Li
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/3/596
_version_ 1797608707248357376
author Yuzhuo Liu
Dongmin Zhao
Jingfeng Zhang
Xinmei Huang
Kaikai Han
Qingtao Liu
Jing Yang
Lijiao Zhang
Yin Li
author_facet Yuzhuo Liu
Dongmin Zhao
Jingfeng Zhang
Xinmei Huang
Kaikai Han
Qingtao Liu
Jing Yang
Lijiao Zhang
Yin Li
author_sort Yuzhuo Liu
collection DOAJ
description Avian influenza virus (AIV) subtype H9N2 is the most widespread AIV in poultry worldwide, causing great economic losses in the global poultry industry. Chickens and ducks are the major hosts and play essential roles in the transmission and evolution of H9N2 AIV. Vaccines are considered an effective strategy for fighting H9N2 infection. However, due to the differences in immune responses to infection, vaccines against H9N2 AIV suitable for use in both chickens and ducks have not been well studied. This study developed an inactivated H9N2 vaccine based on a duck-origin H9N2 AIV and assessed its effectiveness in the laboratory. The results showed that the inactivated H9N2 vaccine elicited significant haemagglutination inhibition (HI) antibodies in both chickens and ducks. Virus challenge experiments revealed that immunization with this vaccine significantly blocked virus shedding after infection by both homogenous and heterologous H9N2 viruses. The vaccine was efficacious in chicken and duck flocks under normal field conditions. We also found that egg-yolk antibodies were produced by laying birds immunized with the inactivated vaccine, and high levels of maternal antibodies were detected in the serum of the offspring. Taken together, our study showed that this inactivated H9N2 vaccine could be extremely favourable for the prevention of H9N2 in both chickens and ducks.
first_indexed 2024-03-11T05:48:21Z
format Article
id doaj.art-9a465dd46b504739a13e754460a847da
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-11T05:48:21Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-9a465dd46b504739a13e754460a847da2023-11-17T14:18:17ZengMDPI AGVaccines2076-393X2023-03-0111359610.3390/vaccines11030596Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and DucksYuzhuo Liu0Dongmin Zhao1Jingfeng Zhang2Xinmei Huang3Kaikai Han4Qingtao Liu5Jing Yang6Lijiao Zhang7Yin Li8Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaInstitute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, ChinaAvian influenza virus (AIV) subtype H9N2 is the most widespread AIV in poultry worldwide, causing great economic losses in the global poultry industry. Chickens and ducks are the major hosts and play essential roles in the transmission and evolution of H9N2 AIV. Vaccines are considered an effective strategy for fighting H9N2 infection. However, due to the differences in immune responses to infection, vaccines against H9N2 AIV suitable for use in both chickens and ducks have not been well studied. This study developed an inactivated H9N2 vaccine based on a duck-origin H9N2 AIV and assessed its effectiveness in the laboratory. The results showed that the inactivated H9N2 vaccine elicited significant haemagglutination inhibition (HI) antibodies in both chickens and ducks. Virus challenge experiments revealed that immunization with this vaccine significantly blocked virus shedding after infection by both homogenous and heterologous H9N2 viruses. The vaccine was efficacious in chicken and duck flocks under normal field conditions. We also found that egg-yolk antibodies were produced by laying birds immunized with the inactivated vaccine, and high levels of maternal antibodies were detected in the serum of the offspring. Taken together, our study showed that this inactivated H9N2 vaccine could be extremely favourable for the prevention of H9N2 in both chickens and ducks.https://www.mdpi.com/2076-393X/11/3/596avian influenza virusH9N2inactivated vaccineprotective efficiencychickenduck
spellingShingle Yuzhuo Liu
Dongmin Zhao
Jingfeng Zhang
Xinmei Huang
Kaikai Han
Qingtao Liu
Jing Yang
Lijiao Zhang
Yin Li
Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
Vaccines
avian influenza virus
H9N2
inactivated vaccine
protective efficiency
chicken
duck
title Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
title_full Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
title_fullStr Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
title_full_unstemmed Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
title_short Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
title_sort development of an inactivated avian influenza virus vaccine against circulating h9n2 in chickens and ducks
topic avian influenza virus
H9N2
inactivated vaccine
protective efficiency
chicken
duck
url https://www.mdpi.com/2076-393X/11/3/596
work_keys_str_mv AT yuzhuoliu developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT dongminzhao developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT jingfengzhang developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT xinmeihuang developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT kaikaihan developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT qingtaoliu developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT jingyang developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT lijiaozhang developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks
AT yinli developmentofaninactivatedavianinfluenzavirusvaccineagainstcirculatingh9n2inchickensandducks